SCHEMBL4955692

SCHEMBL4955692

CC(C)On1ccc2ccc(N)cc21

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRKCI P41743 1/20 0.44
BRPF1 P55201 2/20 0.38
HTR6 P50406 2/20 0.35
HTR2C P28335 5/20 0.34
HTR2A P28223 3/20 0.34
MAPT P10636 4/20 0.33
ALDH1A1 P00352 4/20 0.33
KDM4E B2RXH2 3/20 0.33
GAA P10253 1/20 0.33
GFER P55789 1/20 0.33
NTSR1 P30989 1/20 0.33
NSD2 O96028 1/20 0.32
CYP3A4 P08684 1/20 0.31
HSD17B10 Q99714 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
CHEK1 O14757 1/20 0.31
AURKA O14965 1/20 0.31
DAPK3 O43293 1/20 0.31
CSNK1A1 P48729 1/20 0.31
GSK3A P49840 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4956101 0.81 PRKCI (0.38) PRKCIHTR2CHTR2A
SCHEMBL4949216 0.80 PRKCI (0.44) PRKCIBRPF1HTR6MAPTALDH1A1
SCHEMBL4952843 0.79 HTR2C (0.38) HTR2CHTR2AMAPTALDH1A1KDM4E
SCHEMBL4953458 0.77 PRKCI (0.42) PRKCIBRPF1HTR6HTR2CHTR2A
SCHEMBL4952825 0.76 ALDH1A1 (0.35) PRKCIHTR2CHTR2AMAPTALDH1A1
SCHEMBL4954410 0.76 ALDH1A1 (0.35) PRKCIHTR2CHTR2AMAPTALDH1A1
SCHEMBL6530754 0.74 CDK4 (0.45) BRPF1HTR2CHTR2AMAPTALDH1A1
SCHEMBL4952575 0.74 ACHE (0.35) PRKCIBRPF1HTR2CHTR2AMAPT
SCHEMBL15712463 0.73 PRKCI (0.44) PRKCIBRPF1HTR6HTR2CHTR2A
SCHEMBL4956551 0.71 ALDH1A1 (0.42) PRKCIHTR6MAPTALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7371264-B2 Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof THE PROCTER & GAMBLE COMPANY (US) 2008-05-13 US claimed
US-20060042026-A1 Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof THE PROCTER & GAMBLE COMPANY (US) 2006-03-02 US claimed
US-7371264-B2 Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof THE PROCTER & GAMBLE COMPANY (US) 2008-05-13 US disclosed
EP-1781379-A1 KERATIN DYEING COMPOUNDS, KERATIN DYEING COMPOSITIONS CONTAINING THEM, AND USE THEREOF The Procter and Gamble Company (US) 2007-05-09 EP disclosed
WO-2006026495-A1 KERATIN DYEING COMPOUNDS, KERATIN DYEING COMPOSITIONS CONTAINING THEM, AND USE THEREOF THE PROCTER & GAMBLE COMPANY (US) 2006-03-09 WO disclosed
US-20060042026-A1 Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof THE PROCTER & GAMBLE COMPANY (US) 2006-03-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060042026-A1 Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof KRT18, KDM5A, KDM5C PRKCI 916/4885BRPF1 1273/4885HTR6 1857/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.